Skip to main content
Clinical Trials/NCT03532581
NCT03532581
Completed
Not Applicable

A Novel Surgical Technique: Indocyanine Green Lymphangiography for Identification of the Thoracic Duct During Neck Dissection

Ohio State University Comprehensive Cancer Center1 site in 1 country48 target enrollmentApril 23, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neck Dissection
Sponsor
Ohio State University Comprehensive Cancer Center
Enrollment
48
Locations
1
Primary Endpoint
Recognize injury intra-operatively
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.

Detailed Description

PRIMARY OBJECTIVES: I. Feasibility and optimization of thoracic duct identification using indocyanine green (ICG) lymphangiography. II. To explore specifically how identifying the thoracic duct (TD) will prevent injury intra-operatively. III. To understand if a TD injury can be recognized by leakage of fluorescent chyle into the operating field. OUTLINE: Participants receive indocyanine green solution subcutaneously (SC) and undergo near-infrared imaging over 1-2 minutes during their standard of care neck surgery. After completion of study treatment, participants are followed up for up to 1 year.

Registry
clinicaltrials.gov
Start Date
April 23, 2018
End Date
March 7, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

John Phay, MD

Principal Investigator

Ohio State University Comprehensive Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Healthy adult patients who are undergoing LEFT modified radical or selective (including zone IV) lymph node dissection for any indication; this includes patients who have had prior neck surgery

Exclusion Criteria

  • Children, minors, pregnant women, women who are breast feeding, institutionalized patients
  • Known prior allergic reaction to ICG or allergy to iodine
  • Patients with excessively high anesthesia risks who cannot tolerate the extra time under general anesthesia needed to perform this study; the surgeon and anesthesiologist will determine this pre-operatively

Outcomes

Primary Outcomes

Recognize injury intra-operatively

Time Frame: Up to 1 year

Will be mostly qualitative data collection on how the injury was identified and in what percent.

Prevent injury to the TD

Time Frame: Up to 1 year

Percentage of patients with TD injury will be calculated and compared to contemporary rates of injury.

Identify thoracic duct (TD) using indocyanine green (ICG)

Time Frame: Up to 1 year

We will determine in how many patients the thoracic duct is identified by white light visualization and by ICG fluorescence. The collected data will be primarily qualitative as determined by the surgeon.

Study Sites (1)

Loading locations...

Similar Trials